Argentina has approved Russia's one-dose Sputnik Light as a standalone COVID-19 vaccine and a booster shot, Reuters news agency reported on Monday.
The Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, citing Argentina's health ministry, said a study in Argentina showed Sputnik Light was an "effective universal booster" when combined with vaccines produced by AstraZeneca (LON:AZN), Moderna (Nadaq:MRNA), China's Sinopharm and CanSino Biologics Inc.
RDIF markets Sputnik V internationally.
Reportedly, Argentina was one of the first countries to widely use Russia's Sputnik V COVID-19 vaccine.
AuraVax Therapeutics names new chief executive officer
Sensorion Appoints David Lawrence as Chief Financial Officer
Dynavax Technologies' HEPLISAV B hepatitis drug receives British Marketing Authorisation
Agilent's xCELLigence RTCA HT Platform Now Integrates with the BioTek BioSpa 8 Automated Incubator
Sarlis Named CMO, Head of Clinical Development at Cleara Biotech
GenScript ProBio partners with RVAC Medicines
Bugworks Research adds Dr Renu Swarup as honorary member of the Global Advisory Board